CHESAPEAKE GENERAL HOSPITAL — History
CCN 490120 | 3-year financial timeline | COVID resilience: 48/100
🛡️ Public data only — no PHI permitted on this instance.
$398M
Latest Revenue (FY2022)
+4.5%
Revenue CAGR (3yr)
0.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $365M | $361M | $398M | +10.3% | +4.5% |
| Operating Expenses | $348M | $356M | $394M | +10.9% | +6.4% |
| Operating Margin | 4.5% | 1.5% | 0.9% | -37.0% | -54.5% |
| Net Income | $16M | $5M | $4M | -30.6% | -52.5% |
| Licensed Beds | 310 | 302 | 302 | +0.0% | -1.3% |
| Total Patient Days | 92,529 | 89,675 | 82,602 | -7.9% | -5.5% |
| Medicare Day % | 35% | 33% | 31% | -4.2% | -5.9% |
| Medicaid Day % | 2% | 2% | 3% | +55.5% | +27.0% |
COVID Impact & Recovery
Resilience Score: 48/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +9.2% ($365M → $398M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+4.5%
This Hospital
+7.6%
State Avg
Latest Margin
0.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $415M | -0.9% |
| FY2024 (proj) | $432M | -2.6% |
| FY2025 (proj) | $448M | -4.4% |